Accessibility Menu
Compumedics logo

Compumedics(ASX) CMP

Market CapA$49.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2000)-72%
5 Year-40%
1 Year-17%
1 Month+11%
A$0.24
-4.00%
-0.01Today
Compumedics last closing stock price
MetricPriceDate
Last closeAUD 0.252026-09-07
Compumedics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.96%AUD 0.262026-08-31
1 month+11.11%AUD 0.232026-08-07
3 month+0%AUD 0.252026-06-09
Year to date-25.37%AUD 0.342025-12-31
1 year-16.67%AUD 0.302025-09-05
3 year+38.89%AUD 0.182023-09-07
5 year-39.76%AUD 0.422021-09-08
Since inception-71.58%AUD 0.882000-12-22

Compumedics Financials at a Glance

Market Cap

A$49.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$111.29M

Net Income (TTM)

-A$1.06M

EPS (TTM)

A$0.00

P/E Ratio

250.00

Dividend

A$0.00

Beta (Volatility)

0.00 (Low)

Price

A$0.24

Volume

2,000

Open

A$0.24

Previous Close

A$0.24

Daily Range

A$0.24 - A$0.24

52-Week Range

A$0.22 - A$0.45

Estimated Earnings Date

Aug 27, 2026

CMP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Compumedics

Compumedics Limited is a global medical technology enterprise specializing in advanced diagnostic medical devices. The company focuses on solutions for sleep and neurological disorders, with a market presence across Australia, the Asia Pacific, the Americas, Europe, and the Middle East.

Products and Services
  • Advanced PSG:EEG amplification systems for sleep diagnostics
  • Comprehensive EEG and EMG/EP systems for neurological studies
  • Software solutions for patient data management and workflow optimization
Growth Outlook
  • Recent quarterly revenue reached AUD 30.98 million, a significant increase
  • Strong demand for sleep and neurological diagnostic solutions drives market expansion
  • Investment in R&D supports innovation and product development
Financial Highlights
  • Trailing twelve months revenue of AUD 109.5 million, reflecting growth
  • Net income of AUD 267,000 in the latest quarter, indicating profitability
  • Operating cash flow of AUD 1.8 million demonstrates strong cash generation
Compumedics Limited has established itself as a leader in the medical technology sector, particularly in the fields of sleep and neurological diagnostics. The company's diverse product offerings, including advanced hardware and software solutions, cater to a growing global market. Recent financial performance indicates a positive trajectory, with increasing revenues and a return to profitability in the latest quarter. The focus on research and development positions Compumedics to capitalize on emerging opportunities in the healthcare sector, making it an intriguing option for potential investors.
AI Generated • Aug 24, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

175

CEO

David Burton, PhD

Website

www.compumedics.com.au

Headquarters

Abbotsford, VIC 3067, AU

CMP Financials

Key Financial Metrics (TTM)

Gross Margin

51.41%

Operating Margin

2.97%

Net Income Margin

0.36%

Return on Equity

0.93%

Return on Capital

4.85%

Return on Assets

0.38%

Earnings Yield

0.40%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$49.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

199.76M

Volume

2.00K

Avg. Volume

55.21K

Financials (TTM)

Gross Profit

A$61.97M

Operating Income

A$2.50M

EBITDA

A$5.92M

Operating Cash Flow

A$7.29M

Capital Expenditure

-A$395.00K

Free Cash Flow

A$6.89M

Cash & ST Invst.

A$6.15M

Total Debt

A$14.11M

Compumedics Performance Analysis

Compumedics annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 42,408,00012.3%
20242024-06-30AUD 49,719,00017.2%
20252025-06-30AUD 50,829,0002.2%
20262026-06-30AUD 60,254,00018.5%
Compumedics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-310.9%
Q42025-06-3017.0%
Q22025-12-3112.6%
Q42026-06-30-5.5%
Compumedics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.03N/A
20242024-06-30AUD -0.00-94.5%
20252025-06-30AUD -0.01252.6%
20262026-06-30AUD 0.00N/A
Compumedics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-122.2%
Q42025-06-3085.0%
Q22025-12-31244.4%
Q42026-06-30-115.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$29.28M

+25.6%

Gross Profit

A$15.03M

+30.2%

Gross Margin

51.33%

N/A

Market Cap

A$49.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$285.37K

N/A

Employees

175

N/A

Net Income

-A$53.00K

+88.9%

EBITDA

A$1.63M

+199.1%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$6.15M

+225.2%

Total Debt

A$14.11M

+64.5%

Accounts Receivable

A$12.95M

+16.2%

Inventory

A$13.69M

+3.6%

Long Term Debt

A$3.86M

+367.3%

Short Term Debt

A$10.25M

+32.2%

Return on Assets

0.38%

N/A

Return on Invested Capital

6.28%

N/A

Free Cash Flow

A$4.63M

+530.5%

Operating Cash Flow

A$4.81M

+481.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DOC.AXDoctor Care Anywhere Group PLC
A$0.13+0.00%
CYC.AXCyclopharm Limited
A$0.51+0.00%
M7T.AXMach7 Technologies Limited
A$0.28+0.00%
CSX.AXCleanSpace Holdings Limited
A$0.43-2.30%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.15-0.12%
NVDANvidia
$230.36+0.01%
PATHUiPath
$15.19-0.17%
INTCIntel
$95.80+0.05%

Questions About CMP

What is the current price of Compumedics?

Compumedics is trading at A$0.24 per share.

What is the 52-week range for Compumedics?

Over the past 52 weeks, Compumedics has traded between A$0.22 and A$0.45.

How much debt does Compumedics have?

As of the most recent reporting period, Compumedics reported total debt of A$14.11M.

How much cash does Compumedics have on hand?

Compumedics reported A$6.15M in cash and cash equivalents in its most recent financial results.

What is Compumedics’s dividend yield?

Compumedics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services